Marinus Pharmaceuticals, Inc.
Marinus Pharmaceuticals is a clinical stage biopharmaceutical company committed to improving the lives of patients affected by rare seizure disorders. At Marinus, we are dedicated to the development of investigational ganaxolone, for the potential treatment of pediatric and adult patients with chronic and acute seizure disorders.